GSK plc GSK
NYSE GSK
$48.68 -0.08 (-0.16%)
At close: Oct 29, 2026 · 4:00 PM EDT

Gsk (GSK) Capital Leases (2009 - 2013)

Updated

Gsk's Capital Leases came in at -$32.23 billion for the quarter ended Dec 31, 2013, compared with -$33.36 billion a year earlier.

Analysis

Gsk (GSK) Capital Leases (2009 - 2013) Analysis & Trends

Going back to the quarter ended Dec 31, 2009, Gsk's Capital Leases data covers 5 quarters.

  • Going back by year, Capital Leases was -$33.36 billion in the year ended Dec 31, 2012, -$26.34 billion in the year ended Dec 31, 2011, -$159 million in the year ended Dec 31, 2010 and -$210.37 million in the year ended Dec 31, 2009.
  • The figure for the quarter ended Dec 31, 2013 represents the highest quarterly Capital Leases since the quarter ended Dec 31, 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.17 Bn 1,237.79 Bn 20.46 Bn
2 Johnson & Johnson 660.04 Bn 579.90 Bn 17.30 Bn
3 AbbVie 521.06 Bn 494.17 Bn 12.70 Bn
4 Merck 370.60 Bn 370.60 Bn -
5 Novartis Ag 311.97 Bn 285.20 Bn -
6 Astrazeneca 288.69 Bn 262.37 Bn 12.86 Bn
7 Amgen 252.29 Bn 207.69 Bn 7.24 Bn
8 Gilead Sciences 213.47 Bn 213.47 Bn -
9 Pfizer 173.68 Bn 120.32 Bn 10.94 Bn
10 Gsk 100.27 Bn 83.11 Bn 8.73 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -32.23 Bn
Dec 31, 2012 -33.36 Bn
Dec 31, 2011 -26.34 Bn
Dec 31, 2010 -159.00 Mn
Dec 31, 2009 -210.37 Mn
API Access

Gsk Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=GSK&period=max&api_key=YOUR_API_KEY